Discover TriSalus Life Sciences' Q3 2025 earnings: 57% revenue growth, new product launches, and a reaffirmed 50% growth outlook.

A woman in Delaware has become the first patient to undergo minimally invasive, endovascular surgery with a polymer-based coil. The coil, manufactured by Embolization, Inc., is a vascular embolization ...

IR uses the blood vessel network in the body as almost like a subway map. We can get on and off at different stops to access different parts of the body and treat disease. IR is the intersection of ...

TriSalus Life Sciences Inc (TLSI) reports a 57% revenue increase, expands its product portfolio, and navigates challenges in manufacturing and reimbursement.

The global interventional oncology market size is expected to reach USD 4.38 billion by 2030, registering a CAGR of 8.55% ...

Persistent liver injury halts the regenerative capacity of hepatocytes and activates mechanisms that result in the ...

Experts explore a novel combined therapy for liver-dominant neuroendocrine tumors, enhancing treatment durability with chemotherapy and PRRT. In an interview with Targeted Oncology at the 2025 North ...

According to the NCCN Guidelines for metastatic lung cancer, standard therapies remain valuable, but they are no longer sufficient on their own. This is why molecular profiling, targeted therapy, and ...

A randomized trial of embolization of the middle meningeal artery after surgery for chronic subdural hematoma shows striking ...

Bernie Kosar has undergone procedures to stop internal bleeding as he waits for a liver transplant. The former Cleveland ...

Embolization, Inc. announced that its polymer-based coil intended for arterial and venous embolization in peripheral ...

Browns great Bernie Kosar said Wednesday morning that he underwent "two aggressive procedures" to stop internal bleeding as ...